COVID-19 Vaccine Inequity Catastrophic Moral Failure, Says WHO

Ryan while speaking at a virtual press conference from Geneva on Monday stressed that there was no "golden solution" to end the pandemic and also talked about the recent rise of cases in Europe up by "12 percent" in the last week

Executive Director of World Health Organisation (WHO) Health Emergencies Program, Michael Ryan,  said on Monday that the “inequitable” COVID-19 vaccine distribution was a “catastrophic moral failure” and a “failed opportunity.”

Ryan while speaking at a virtual press conference from Geneva on Monday stressed that there was no “golden solution” to end the pandemic and also talked about the recent rise of cases in Europe up by “12 percent” in the last week.

He said that many countries have the strategy to “get enough vaccine” and “push enough vaccine to people,” assuming that the COVID-19 pandemic would be shaken off with vaccine rollouts. “I am sorry, it is not(the case),” he said. “There are not enough vaccines in the world, and they are distributed terribly iniquitously.”

“In fact, we have missed a huge opportunity to bring vaccines on board as a comprehensive measure,” said Ryan. “It is not only a catastrophic moral failure, but it is (also) an epidemiologic failure.” Last week the global infections rose up instantly and among the most affected places was South Asia, which saw a surge of 49 percent in the number of cases, with India taking the bulk of the rise.

Other than this another hotspot was Western Pacific, with the Philippines and Papua New Guinea accounting for most of the 29 percent increase.

Meanwhile, the gap in vaccine procurement between richer and poorer countries “is growing every single day,” warned Tedros Adhanom Ghebreyesus, Director-General of the WHO, at Monday’s press conference.

However, the world is struggling to control the pandemic and the vaccination is underway in an increasing number of countries with the already-authorized coronavirus vaccines.

Meanwhile, 264 candidate vaccines are still being developed worldwide — 82 of them in clinical trials — in countries including Germany, China, Russia, Britain, and the United States, according to the latest information released by the World Health Organization.

Facebook Comments